Announced details
The Company applied to the Organization for Small & Medium Enterprises and Regional Innovation, Japan to have its ¥10 Billion Declaration posted, and the application was accepted. The Company invested in アイ・ブレインサイエンス社 through its subsidiary バイオ・サイト・キャピタル株式会社.
The Organization for Small & Medium Enterprises and Regional Innovation, Japan (SME Support, Japan) operates the ¥10 Billion Enterprise Growth Portal. アイ・ブレインサイエンス社 develops MIRUDAKE, an AI-powered app for diagnosing dementia. Other information, including its location, representative, capital and year of establishment, is not disclosed.
Approximately ¥50 million (investment in アイ・ブレインサイエンス社)
The Company aims to achieve annual sales of ¥10 billion in 2028. The specific impact on results from acceptance of the ¥10 Billion Declaration itself is not disclosed.
The company does not address Offering price.
The ¥10 Billion Enterprise Growth Portal, operated by SME Support, Japan under the supervision of the Small and Medium Enterprise Agency
| Item | Details |
|---|---|
| Names of Products / Services Covered | ¥10 Billion Declaration, ¥10 Billion Enterprise Growth Portal, MIRUDAKE |
| Counterparty | Organization for Small & Medium Enterprises and Regional Innovation, Japan, アイ・ブレインサイエンス社 |
| Counterparty overview | The Organization for Small & Medium Enterprises and Regional Innovation, Japan (SME Support, Japan) operates the ¥10 Billion Enterprise Growth Portal. アイ・ブレインサイエンス社 develops MIRUDAKE, an AI-powered app for diagnosing dementia. Other information, including its location, representative, capital and year of establishment, is not disclosed. |
| Relationship with the Company | The Company applied to the Organization for Small & Medium Enterprises and Regional Innovation, Japan to have its ¥10 Billion Declaration posted, and the application was accepted. The Company invested in アイ・ブレインサイエンス社 through its subsidiary バイオ・サイト・キャピタル株式会社. |
| Contract Value | Approximately ¥50 million (investment in アイ・ブレインサイエンス社) |
| Applicable area | Real estate business (senior living facilities), Merchandise sales and healthcare-related businesses, Biotechnology and healthcare, Investment and M&A |
| Impact on Business Performance | The Company aims to achieve annual sales of ¥10 billion in 2028. The specific impact on results from acceptance of the ¥10 Billion Declaration itself is not disclosed. |
| Source | The ¥10 Billion Enterprise Growth Portal, operated by SME Support, Japan under the supervision of the Small and Medium Enterprise Agency |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To give concrete form to and promote initiatives enabling small and medium-sized enterprises to achieve rapid growth. The Company views Japan's aging population and inflation as growth opportunities and will shift to a business portfolio centered on real estate, merchandise sales and investment, thereby establishing a foundation for sustainable growth.